Biofire-Respiratory Panel

What is the Biofire-Respiratory Panel Test?

Because a large number of pathogens cause respiratory infections, tests that only identify SARS-CoV-2 or influenza run the risk of missing the real culprit. In fact, SARS-CoV-2 has been detected in respiratory samples <10% of the time in the United States.5 And many rapid influenza diagnostic tests sacrifice accuracy for speed, with sensitivities ranging from 50–70%.6

​

The multiplex PCR BioFire RP2.1-EZ Panel (EUA)* provides a rapid and comprehensive alternative to targeted testing and will detect a greater number of pathogens no matter the season or the time of year.  If you want to tip the balance in your favor of determining what is really wrong, this test gives you great odds.

19 Targets in One Test

The BioFire RP2.1-EZ Panel (EUA)* is a syndromic test with the ability to identify 15 viral and 4 bacterial respiratory pathogens in patients suspected of SARS-CoV-2. As the name implies, it’s easy and takes just one nasopharyngeal swab with results in about 60-90 minutes.